Group One Trading
FBRX icon

Group One Trading’s Forte Biosciences FBRX Stock Holding History

Group One Trading’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21K Sell
104
-100
-49% -$2.37K ﹤0.01% 7017
2026
Q1 		$5.28K Hold
204
– – ﹤0.01% 6685
2025
Q4 		$5.56K Buy
204
+100
+96% +$1.75K ﹤0.01% 7136
2025
Q3 		$1.56K Hold
104
– – ﹤0.01% 7969
2025
Q2 		$1.34K Hold
104
– – ﹤0.01% 7507
2025
Q1 		$807 Hold
104
– – ﹤0.01% 7215
2024
Q4 		$2.36K Sell
104
-455
-81% -$5.41K ﹤0.01% 6683
2024
Q3 		$3.13K Sell
559
-2
-0.4% -$21 ﹤0.01% 6033
2024
Q2 		$7.53K Sell
561
-20
-3% -$323 ﹤0.01% 5766
2024
Q1 		$10.2K Sell
581
-52
-8% -$907 ﹤0.01% 5852
2023
Q4 		$13K Hold
633
– – ﹤0.01% 6034
2023
Q3 		$10.5K Sell
633
-21
-3% -$465 ﹤0.01% 6319
2023
Q2 		$17K Buy
654
+420
+179% +$10.9K ﹤0.01% 6085
2023
Q1 		$5.9K Sell
234
-82
-26% -$2.06K ﹤0.01% 6211
2022
Q4 		$7.89K Sell
316
-446
-59% -$11.4K ﹤0.01% 6130
2022
Q3 		$20K Hold
762
– – ﹤0.01% 6069
2022
Q2 		$25K Hold
762
– – ﹤0.01% 6107
2022
Q1 		$28K Sell
762
-214
-22% -$8.1K ﹤0.01% 6517
2021
Q4 		$52K Sell
976
-542
-36% -$36.5K ﹤0.01% 6305
2021
Q3 		$112K Buy
+1,518
New +$841K ﹤0.01% 5796
2020
Q3 		– Sell
-7
Closed -$2K – 6218
2020
Q2 		$2K Sell
7
-47
-87% -$21K ﹤0.01% 5549
2020
Q1 		$25K Sell
54
-38
-41% -$14.8K ﹤0.01% 4110
2019
Q4 		$18K Buy
92
+23
+33% +$5.21K ﹤0.01% 4395
2019
Q3 		$17K Buy
69
+26
+60% +$39.5K ﹤0.01% 4400
2019
Q2 		$108K Buy
43
+33
+330% +$97.9K ﹤0.01% 3293
2019
Q1 		$41K Buy
10
+7
+233% +$27K ﹤0.01% 3659
2018
Q4 		$11K Buy
+3
New +$12.9K ﹤0.01% 4224

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Group One Trading's FBRX Position: Q2 2026 in Review

Group One Trading reduced its Forte Biosciences (FBRX) stake by 49% in Q2 2026, selling an estimated $2.37K and leaving 104 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #7017.

Group One Trading first reported a position in FBRX in Q4 2018 and has held it in 27 quarters since. The position peaked at $112K in Q3 2021. 57 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Group One Trading held 104 shares of Forte Biosciences worth $2.21K as of Q2 2026.
  • Group One Trading sold 100 Forte Biosciences shares in Q2 2026, an estimated $2.37K.
  • Forte Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7017 holding.
  • Group One Trading first reported a position in Forte Biosciences in Q4 2018 and has held it in 27 quarters since.
  • Group One Trading's Forte Biosciences position peaked at $112K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.